The growing prevalence of anaphylaxis and surging aging population are two of the key factors responsible for the growth of the auto-injectors market. The market is predicted to advance at a CAGR of 18.6% during the forecast period (2017–2023). An auto-injector is a medical device used for injecting a particular dose of drugs in patients. Most of the auto-injectors are spring-loaded syringes, designed for the safe dispensation of drugs with ease. Based on product, the auto-injectors market is bifurcated into prefilled and fillable injectors.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/auto-injectors-market/report-sample
As per the Asthma and Allergy Foundation of America (AAFA), a sudden allergic reaction that affects two or more organs, such as the lungs, skin, heart, and stomach, is termed as anaphylaxis. It has been observed that anaphylaxis is more common in the U.S. and found in one out of every 20 Americans. Two of the key causes of anaphylaxis include insects and consumption of foods and medicines the body is allergic to. In developing and developed nations, the incidence of food-related anaphylaxis is increasing, which, in turn, is resulting in the growth of the auto-injectors market.
The surging prevalence of anaphylaxis, RA, and MS is compelling healthcare providers and government organizations to offer improved products and facilities for effective disease treatment. This, in turn, would result in the increasing number of technologically improved products’ launches across the globe. Most of the biologics, including anticoagulants, monoclonal antibodies, and vaccines, are large molecules which need parenteral administration to achieve the required therapeutic effects, which is why various biologic drugs and vaccines are injected directly into the blood stream.